Mar, in looking over the two Cramer 'pumps', even though he gave MYOG second billing, it look like the better stock, for sure. Obviously, though, everyone will go for ZGEN because it's 'cheaper?'for the 'play'. It's drug is only in Stage 1b trials....makes me think even $20 is lofty. but wthdik?